Literature DB >> 25073493

Lactobezoar formation in two premature infants receiving medium-chain triglyceride formula.

M Prahl1, D Smetana1, N Porta2.   

Abstract

We describe two cases of premature infants who developed clinical and radiologic evidence of gastric lactobezoars within the same month in our neonatal intensive care unit while both were receiving medium-chain triglyceride-rich formula as part of the management of chylothoraces.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25073493     DOI： 10.1038/jp.2014.78

Source DB:  PubMed          Journal:  J Perinatol        ISSN： 0743-8346            Impact factor:   2.521


  7 in total

1.  Gastrotomy for lactobezoar in a newborn infant.

Authors:  R S WOLF; J BRUCE
Journal:  J Pediatr       Date:  1959-06       Impact factor: 4.406

Review 2.  Lactobezoars: a patient series and literature review.

Authors:  T M DuBose; W M Southgate; J G Hill
Journal:  Clin Pediatr (Phila)       Date:  2001-11       Impact factor: 1.168

3.  Management of chylothorax in children by thoracentesis and medium-chain triglyceride feedings.

Authors:  A M Kosloske; L W Martin; W K Schubert
Journal:  J Pediatr Surg       Date:  1974-06       Impact factor: 2.545

Review 4.  Nutrition support in the pediatric surgical patient.

Authors:  Richard Herman; Imad Btaiche; Daniel H Teitelbaum
Journal:  Surg Clin North Am       Date:  2011-06       Impact factor: 2.741

5.  Congenital chylothorax.

Authors:  K Al-Tawil; G Ahmed; M Al-Hathal; Y Al-Jarallah; N Campbell
Journal:  Am J Perinatol       Date:  2000       Impact factor: 1.862

Review 6.  Use of Monogen for pediatric postoperative chylothorax.

Authors:  Barbara E Cormack; Nigel J Wilson; Kirsten Finucane; Teena M West
Journal:  Ann Thorac Surg       Date:  2004-01       Impact factor: 4.330

Review 7.  Gastric lactobezoar - a rare disorder?

Authors:  Peter Heinz-Erian; Ingmar Gassner; Andreas Klein-Franke; Veronika Jud; Rudolf Trawoeger; Christian Niederwanger; Thomas Mueller; Bernhard Meister; Sabine Scholl-Buergi
Journal:  Orphanet J Rare Dis       Date:  2012-01-04       Impact factor: 4.123
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.